JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB167136

Anti-NRAS抗体

Anti-NRAS antibody

4

(8 Reviews)

|

(6 Publications)

Anti-NRAS antibody (ab167136) is a rabbit polyclonal antibody detecting NRAS in Western Blot. Suitable for Human.

- KO validated for confirmed specificity

查看别名

HRAS1, NRAS, GTPase NRas, Transforming protein N-Ras

4 Images
Western blot - Anti-NRAS antibody (AB167136)
  • WB

Lab

Western blot - Anti-NRAS antibody (AB167136)

False colour image of Western blot : Anti-NRAS antibody staining at 0.5 ug/ml, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab167136 was shown to bind specifically to NRAS. A band was observed at 21 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in NRAS CRISPR-Cas9 edited cell line ab266684 (NRAS CRISPR-Cas9 edited cell lysate ab258542). The band observed in the CRISPR-Cas9 edited lysate lane above 21 kDa is likely to represent NRAS with an insertion. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and NRAS CRISPR-Cas9 edited HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-NRAS antibody (ab167136) at 0.5 µg/mL

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

NRAS knockout HEK-293T cell lysate at 20 µg

Lane 3:

MCF7 cell lysate at 20 µg

Lane 4:

A549 cell lysate at 20 µg

Predicted band size: 21 kDa

Observed band size: 21 kDa

false

Western blot - Anti-NRAS antibody (AB167136)
  • WB

Unknown

Western blot - Anti-NRAS antibody (AB167136)

Lane 1:

Western blot - Anti-NRAS antibody (ab167136) at 1 µg/mL

Lane 2:

Western blot - Anti-NRAS antibody (ab167136) at 2 µg/mL

All lanes:

293 cell lysate at 15 µg

Predicted band size: 21 kDa

false

Western blot - Anti-NRAS antibody (AB167136)
  • WB

Unknown

Western blot - Anti-NRAS antibody (AB167136)

Western Blot of A431 cell lysate labeling NRAS with Anti-NRAS antibody - C-terminal (ab167136) at (1) 1 and (2) 2μg/ml.

All lanes:

Western blot - Anti-NRAS antibody (ab167136)

Predicted band size: 21 kDa

false

Western blot - Anti-NRAS antibody (AB167136)
  • WB

Lab

Western blot - Anti-NRAS antibody (AB167136)

Lanes 1 - 4 : Merged signal (red and green). Green - ab167136 observed at 22 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.

ab167136 was shown to react with NRAS in wild-type HEK-293T cells in Western blot with loss of signal observed in NRAS knockout cell line ab266684 (NRAS knockout cell lysate ab258542). Wild-type HEK-293T and NRAS knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab167136 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at 0.5 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-NRAS antibody (ab167136) at 0.5 µg/mL

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

NRAS knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human NRAS knockout HEK-293T cell line (<a href='/products/cell-lines/human-nras-knockout-hek-293t-cell-line-ab266684'>ab266684</a>)

Lane 3:

MCF7 cell lysate at 20 µg

Lane 4:

A549 cell lysate at 20 µg

Predicted band size: 21 kDa

Observed band size: 22 kDa

false

关键信息

宿主种属

Rabbit

克隆

Polyclonal

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

WB

applications

免疫原

Synthetic Peptide within Human NRAS. The exact immunogen used to generate this antibody is proprietary information.

P01111

特异性

ab167136 is predicted to not cross-react with H-RAS.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.5-2 µg/mL", "WB-species-notes": "<p></p>" } } }

产品详情

What is this antibody validated in?
Anti-NRAS antibody (ab167136) is a rabbit polyclonal antibody and is validated for use in Western Blot (WB) in Human samples.

What is the molecular weight of NRAS?
Anti-NRAS (ab167136) specifically detects a band for NRAS (UniProt: P01111) at a molecular weight of 21kDa.

Reviewed by scientists
Anti-NRAS (ab167136) has over 5 independent reviews from customers.

Specificity confirmed
The specificity of Anti-NRAS antibody (ab167136) has been confirmed by Western blot testing in NRAS Knockout HEK293T cell line, ab266684.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
存储溶液
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The NRAS protein also known as neuroblastoma RAS viral oncogene homolog has a molecular weight of approximately 24 kDa. It functions mechanically as a GTPase cycling between an inactive GDP-bound state and an active GTP-bound state. The NRAS gene which encodes this protein shows expression in various tissues including the thymus leukocytes and other cells of the hematopoietic lineage. Activation of RAS involves the conversion to the GTP-bound form which enables NRAS to transmit signals within cells.
Biological function summary

NRAS plays an important role in cell proliferation differentiation and survival. It does not function alone but is part of the larger RAS protein family including HRAS and KRAS with whom it shares similar roles and sequence homology. NRAS interacts with various growth factor receptors and mediates signals to downstream effectors that influence cellular processes. Mutations in the NRAS gene can affect these biological processes leading to altered cell behavior.

Pathways

NRAS has significant roles in the MAPK/ERK pathway and the PI3K/AKT pathway. These pathways regulate fundamental cellular functions including growth and survival. NRAS interacts closely with other proteins such as RAF kinases and PI3K to propagate signals from activated receptors at the cell membrane to the nucleus. Altered NRAS activity can impact these pathways affecting cellular responses to external stimuli.

NRAS mutations are linked to certain cancers including melanoma and acute myeloid leukemia (AML). Mutant forms of NRAS result in constitutively activated RAS contributing to uncontrolled cell growth and survival. In melanoma NRAS mutations frequently co-occur with alterations in other proteins such as BRAF another member of the RAS/RAF/MEK/ERK pathway. Understanding NRAS's involvement in these conditions is critical for developing targeted therapeutic strategies.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
See full target information NRAS

文献 (6)

Recent publications for all applications. Explore the full list and refine your search

Oncogene 43:3489-3497 PubMed39379700

2024

Inhibition and degradation of NRAS with a pan-NRAS monobody.

Applications

Unspecified application

Species

Unspecified reactive species

Michael Whaby,Gayatri Ketavarapu,Akiko Koide,Megan Mazzei,Mubashir Mintoo,Eliezra Glasser,Unnatiben Patel,Cecile Nasarre,Matthew J Sale,Frank McCormick,Shohei Koide,John P O'Bryan

Nature cancer 5:1352-1370 PubMed39103541

2024

Co-targeting SOS1 enhances the antitumor effects of KRAS inhibitors by addressing intrinsic and acquired resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Venu Thatikonda,Hengyu Lyu,Sabine Jurado,Kaja Kostyrko,Christopher A Bristow,Christoph Albrecht,Donat Alpar,Heribert Arnhof,Oliver Bergner,Karin Bosch,Ningping Feng,Sisi Gao,Daniel Gerlach,Michael Gmachl,Melanie Hinkel,Simone Lieb,Astrid Jeschko,Annette A Machado,Thomas Madensky,Ethan D Marszalek,Mikhila Mahendra,Gabriella Melo-Zainzinger,Jessica M Molkentine,Philipp A Jaeger,David H Peng,Robyn L Schenk,Alexey Sorokin,Sandra Strauss,Francesca Trapani,Scott Kopetz,Christopher P Vellano,Mark Petronczki,Norbert Kraut,Timothy P Heffernan,Joseph R Marszalek,Mark Pearson,Irene C Waizenegger,Marco H Hofmann

Science advances 9:eadf4766 PubMed37450595

2023

RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy.

Applications

Unspecified application

Species

Unspecified reactive species

Antonio Cuevas-Navarro,Morgan Wagner,Richard Van,Monalisa Swain,Stephanie Mo,John Columbus,Madeline R Allison,Alice Cheng,Simon Messing,Thomas J Turbyville,Dhirendra K Simanshu,Matthew J Sale,Frank McCormick,Andrew G Stephen,Pau Castel

NPJ precision oncology 6:86 PubMed36418474

2022

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas McFall,Michael Trogdon,Anita C Guizar,John F Langenheim,Laura Sisk-Hackworth,Edward C Stites

Cell reports 37:110096 PubMed34910921

2021

Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas McFall,Edward C Stites

PloS one 12:e0182044 PubMed28763470

2017

UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.

Applications

Unspecified application

Species

Unspecified reactive species

Javier Martinez-Useros,Tihomir Georgiev-Hristov,María Jesús Fernández-Aceñero,Aurea Borrero-Palacios,Alberto Indacochea,Santiago Guerrero,Weiyao Li,Arancha Cebrián,Teresa Gómez Del Pulgar,Alberto Puime-Otin,Laura Del Puerto-Nevado,María Rodríguez-Remírez,Nuria Pérez,Angel Celdrán,Fátima Gebauer,Jesus Garcia-Foncillas
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com